Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.10−0.02 (-0.94%)
Close on Nov 13, 2026Market cap $198.56MP/E 5.5Yield –
Compugen profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was 48.6%, against -51.1% the year before. The highest annual figure on record is 48.6% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 48.6% | +99.6 |
| FY2024 | Dec 31, 2024 | -51.1% | +5.0 |
| FY2023 | Dec 31, 2023 | -56.1% | +393.2 |
| FY2022 | Dec 31, 2022 | -449.3% | +120.8 |
| FY2021 | Dec 31, 2021 | -570.0% | +914.9 |
| FY2020 | Dec 31, 2020 | -1484.9% | −1357.9 |
| FY2018 | Dec 31, 2018 | -127.0% | +4298.0 |
| FY2016 | Dec 31, 2016 | -4425.0% | −4207.7 |
| FY2015 | Dec 31, 2015 | -217.3% | −127.6 |
| FY2014 | Dec 31, 2014 | -89.7% | +307.1 |
| FY2013 | Dec 31, 2013 | -396.8% | +5234.6 |
| FY2012 | Dec 31, 2012 | -5631.4% | −4985.4 |
| FY2010 | Dec 31, 2010 | -646.0% | +886.4 |
| FY2009 | Dec 31, 2009 | -1532.4% | – |
See a number that looks wrong?